MedTrace Logo

Efficacy and Safety of Synthetic Phosphoethanolamine in Solid Tumor Patients

NCT02950103 · Status: TERMINATED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 73

Last updated 2019-09-30

No results posted yet for this study

Summary

Synthetic phosphoethanolamine is a primary amine which has a critical role in the biosynthesis of cell membranes. Pre-clinical models have shown potential anticancer activity.

Conditions

Interventions

DRUG

Phosphoethanolamine

Phosphoethanolamine PO daily

Sponsors & Collaborators

  • Instituto do Cancer do Estado de São Paulo

    collaborator OTHER

  • Secretaria de Estado da Saúde

    lead OTHER_GOV

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-08-31
Primary Completion
2017-03-31
Completion
2019-09-30

Countries

  • Brazil

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02950103 on ClinicalTrials.gov